Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
scientific article published on 4 May 2017
Author/s
author: Christopher Griffiths, Kim A. Papp, Ramon M Pujol, Jacek Szepietowski, Karel Ettler, Karel Ettler, Lajos Kemény, Andrew Blauvelt, Eric Simpson, Gianluca Pirozzi, Vera Mastey, Neil Stahl, Melinda Gooderham, Jamie Weisman
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.